{"url_path":"/sec/silo/8-k/2026-06-03/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-064804-index.html","accession_number":"0001213900-26-064804","cik":"0001514183","ticker":"SILO","issuer_name":"Silo Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-064804-index.html","primary_entity_key":"0001514183","primary_entity_name":"Silo Pharma, Inc."},"word_count":75,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01 Financial\nStatements and Exhibits.**\n\n \n\n(d) *Exhibits*\n\n* *\n\n**Exhibit** \nDescription\n\n3.1 \n[Certificate of Change](ea029311101ex3-1.htm)\n\n104 \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**SILO PHARMA, INC.**\n\n \n \n \n\nDate: June 3, 2026\nBy: \n/s/ Eric Weisblum\n\n \n \nEric Weisblum\n\n \n \nChief Executive Officer\n\n \n\n2"}